Phospho-ITGB3 (Y773) Antibody

What is the Phospho-ITGB3 (Y773) Antibody and its biological significance?

Phospho-ITGB3 (Y773) Antibody specifically detects endogenous levels of Integrin beta-3 protein only when phosphorylated at tyrosine 773. This antibody is crucial for studying integrin signaling, as ITGB3 (Integrin beta-3) forms heterodimers with various alpha subunits, particularly alpha-V and alpha-IIb, to create functional receptors. These receptors bind to extracellular matrix components including fibronectin, collagen, and vitronectin . The phosphorylation at Y773 is particularly significant as it mediates key signaling events in platelets and endothelial cells. ITGAV:ITGB3 interaction with pleiotrophin (PTN) forms a complex with PTPRZ1 that stimulates endothelial cell migration specifically through ITGB3 Tyr-773 phosphorylation . This makes the antibody an essential tool for studying angiogenesis, thrombosis, and cell adhesion mechanisms.

What are the technical specifications of commercially available Phospho-ITGB3 (Y773) antibodies?

Commercially available Phospho-ITGB3 (Y773) antibodies share several common specifications while exhibiting minor variations between manufacturers. These antibodies are typically rabbit polyclonal IgGs supplied at a concentration of 1mg/ml in PBS with 0.02% sodium azide and 50% glycerol at pH 7.2 . The immunogen used for antibody production is a synthetic phosphopeptide derived from human Integrin β3 around the phosphorylation site of Tyrosine 773 . The calculated molecular weight of the target protein is approximately 87kDa, though observed weight may vary to around 110kDa due to post-translational modifications . These antibodies generally show cross-reactivity with human, mouse, and rat samples, making them versatile for comparative studies across species .

How do I design control experiments when using Phospho-ITGB3 (Y773) antibody?

Designing appropriate controls is critical when working with phospho-specific antibodies like Phospho-ITGB3 (Y773). A comprehensive control strategy should include both positive and negative controls to validate specificity and minimize false interpretations. For positive controls, use samples known to exhibit high levels of ITGB3 Y773 phosphorylation, such as activated platelets or endothelial cells stimulated with growth factors that enhance integrin signaling . Negative controls should include samples where phosphorylation is deliberately reduced or absent - this can be achieved through phosphatase treatment of lysates or using pharmacological inhibitors of kinases responsible for Y773 phosphorylation.

Additionally, blocking peptide controls are highly recommended. These synthetic phosphopeptides (the same used as immunogens) can be pre-incubated with the antibody before sample application to competitively inhibit specific binding . This approach helps distinguish between specific and non-specific signals. For quantitative assays, consider using recombinant ITGB3 proteins with and without Y773 phosphorylation as calibration standards. Finally, genetic controls using ITGB3 knockout models or Y773F mutation (preventing phosphorylation at this site) provide the most rigorous validation of antibody specificity in biological contexts.

What are the optimal protocols for immunohistochemistry using Phospho-ITGB3 (Y773) antibody?

Immunohistochemistry (IHC) is one of the primary validated applications for Phospho-ITGB3 (Y773) antibody. For optimal results, follow this comprehensive protocol adapted from validated procedures:

Tissue Preparation and Fixation:
Begin with freshly collected tissues fixed in 10% neutral buffered formalin for 24-48 hours, followed by paraffin embedding. Cut sections at 4-6μm thickness and mount on positively charged slides. Immediate fixation is critical for preserving phosphorylation status .

Antigen Retrieval:
Heat-induced epitope retrieval is recommended using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0). Heat in a pressure cooker or microwave until boiling, then maintain at sub-boiling temperature for 10-20 minutes. Allow slides to cool in retrieval solution for 20 minutes at room temperature .

Blocking and Antibody Incubation:

• Block endogenous peroxidase with 3% hydrogen peroxide for 10 minutes

• Apply protein block (5% normal goat serum) for 30 minutes

• Incubate with Phospho-ITGB3 (Y773) antibody at dilutions between 1:50-1:200 (optimally 1:100) overnight at 4°C

• Apply appropriate HRP-conjugated secondary antibody for 30 minutes at room temperature

• Develop with DAB substrate and counterstain with hematoxylin

Critical Considerations:
For phospho-specific staining, phosphatase inhibitors (1mM sodium orthovanadate, 5mM sodium fluoride) should be included in all buffer solutions to preserve phosphorylation status. Parallel staining with total ITGB3 antibody on sequential sections provides valuable comparative data. For breast carcinoma tissue, which has shown consistent results, a 1:100 dilution is recommended as a starting point .

How can I optimize Western blot conditions for detecting phosphorylated ITGB3 at Y773?

Western blot optimization for phospho-ITGB3 (Y773) requires careful attention to sample preparation and experimental conditions to preserve phosphorylation status and maximize signal specificity:

Sample Preparation:

• Harvest cells or tissues in ice-cold RIPA buffer supplemented with phosphatase inhibitors (10mM sodium fluoride, 1mM sodium orthovanadate, 1mM sodium pyrophosphate, and 1mM β-glycerophosphate)

• Homogenize rapidly and keep samples on ice throughout processing

• Clarify lysates by centrifugation at 14,000×g for 15 minutes at 4°C

• Determine protein concentration using a compatible assay (BCA recommended)

• Add Laemmli buffer and heat at 70°C (not boiling) for 5 minutes to minimize phospho-epitope destruction

Gel Electrophoresis and Transfer:

• Load 20-40μg of total protein per lane

• Use 7.5% SDS-PAGE gels to properly resolve the 87-110kDa ITGB3 protein

• Include phosphorylated protein markers

• Transfer to PVDF membrane (not nitrocellulose) using wet transfer at 30V overnight at 4°C for high molecular weight proteins

Antibody Incubation and Detection:

• Block with 5% BSA (not milk, which contains phosphatases) in TBST for 1 hour

• Incubate with Phospho-ITGB3 (Y773) antibody at 1:500-1:1000 dilution in 5% BSA/TBST overnight at 4°C

• Wash extensively (4×10 minutes) with TBST

• Incubate with HRP-conjugated anti-rabbit secondary antibody at 1:5000

• Develop using enhanced chemiluminescence with extended exposure times if necessary

Validation and Controls:
Include lysates from cells treated with integrin activators (e.g., Mn2+, fibronectin) as positive controls, and lysates treated with lambda phosphatase as negative controls. Stripping and reprobing the same membrane with total ITGB3 antibody provides crucial normalization data for quantifying the proportion of phosphorylated protein.

What approaches should be used for quantifying ITGB3 (Y773) phosphorylation in experimental systems?

Quantifying ITGB3 Y773 phosphorylation requires a multi-faceted approach to ensure accuracy and biological relevance. Several complementary methods can be employed:

Western Blot Densitometry:

• Always normalize phospho-ITGB3 (Y773) signal to total ITGB3 levels from the same samples

• Use linear range exposure times determined through standard curves

• Employ image analysis software (ImageJ, Image Lab) with background subtraction

• Report results as phospho-ITGB3/total ITGB3 ratio across multiple independent experiments

• Include both biological and technical replicates (n≥3)

Quantitative Immunofluorescence:

• Co-stain samples with phospho-ITGB3 (Y773) and total ITGB3 antibodies using spectrally distinct fluorophores

• Capture images using consistent exposure settings

• Measure mean fluorescence intensity using cell-by-cell analysis

• Calculate phospho/total ratios at subcellular levels (focal adhesions vs. cytoplasmic)

• Employ high-content imaging systems for larger datasets when possible

Flow Cytometry:

• Fix cells with 2% paraformaldehyde followed by permeabilization

• Stain with phospho-ITGB3 (Y773) and total ITGB3 antibodies

• Use median fluorescence intensity for quantification

• Consider dual staining with markers of cell activation or other signaling pathways

Phospho-proteomics:
For more comprehensive analysis, quantitative phospho-proteomics using stable isotope labeling and mass spectrometry can provide stoichiometric measurements of Y773 phosphorylation relative to other ITGB3 phosphorylation sites and the total ITGB3 pool.

How does ITGB3 Y773 phosphorylation contribute to integrin activation and cell migration?

ITGB3 Y773 phosphorylation serves as a critical molecular switch in the complex process of integrin activation and cell migration. The phosphorylation of this specific tyrosine residue initiates a cascade of conformational changes and protein-protein interactions that modulate integrin function. Mechanistically, Y773 phosphorylation disrupts the interaction between the integrin β3 cytoplasmic tail and cytoskeletal restraints, allowing the integrin to adopt an extended, active conformation that increases affinity for extracellular ligands .

In endothelial cells, Y773 phosphorylation occurs following formation of a complex between integrin αVβ3, pleiotrophin (PTN), and the receptor protein tyrosine phosphatase PTPRZ1. This complex formation specifically triggers ITGB3 phosphorylation at Y773, which subsequently stimulates endothelial cell migration - a process essential for angiogenesis . Similarly, in platelets, ITGB3 Y773 phosphorylation following fibrinogen binding enhances P-selectin (SELP) expression, reinforcing platelet activation and aggregation .

Research using phospho-mimetic mutations (Y773D or Y773E) and phospho-deficient mutations (Y773F) has demonstrated that this phosphorylation event regulates the recruitment of specific adaptor proteins like Shc and Grb2 to integrin-containing adhesion complexes. These adaptors link integrin signaling to the Ras-MAPK pathway, thereby modulating cell proliferation and migration. The temporal dynamics of Y773 phosphorylation (rapid and transient versus sustained) appear to determine whether cells undergo directed migration versus stable adhesion.

What experimental systems are most suitable for studying ITGB3 Y773 phosphorylation dynamics?

Selecting appropriate experimental systems is crucial for investigating the dynamics of ITGB3 Y773 phosphorylation. Both in vitro and in vivo models offer complementary advantages:

Cell Culture Models:

• Endothelial cells (HUVECs, HMEC-1): Ideal for studying angiogenesis and endothelial migration, these cells express high levels of αVβ3 integrin and show robust Y773 phosphorylation in response to growth factors and extracellular matrix interactions .

• Platelet isolation and activation assays: Fresh platelet preparations allow for investigation of rapid Y773 phosphorylation during activation. Time-course studies following thrombin or ADP stimulation reveal phosphorylation kinetics .

• Osteoblast cell lines: Since Integrin β3 isoform β-3A is specifically expressed in osteoblast cells, these provide a unique system for studying isoform-specific phosphorylation patterns .

Advanced In Vitro Systems:

• Microfluidic devices: Allow real-time imaging of Y773 phosphorylation under controlled flow conditions, mimicking vascular environments

• 3D matrix models: Better recapitulate the in vivo extracellular environment for studying phosphorylation during matrix invasion and migration

• Co-culture systems: Examine how cell-cell interactions affect Y773 phosphorylation (e.g., tumor cell-endothelial cell interactions)

In Vivo Models:

• Transgenic mouse models: Knock-in mice expressing ITGB3-Y773F provide powerful tools for understanding the physiological relevance of this phosphorylation site

• Intravital microscopy: Combines in vivo models with real-time imaging of phosphorylation events in tissue contexts

• Injury models: Vascular injury, wound healing, or ischemia models reveal context-dependent phosphorylation patterns

Patient-Derived Samples:
Analysis of Y773 phosphorylation in human samples (e.g., tumor biopsies, isolated platelets from patients with thrombotic disorders) provides clinically relevant insights. Paraffin-embedded breast carcinoma tissue has shown reliable results for phospho-Y773 ITGB3 detection by IHC .

What is the relationship between ITGB3 Y773 phosphorylation and other integrin signaling pathways?

ITGB3 Y773 phosphorylation functions within an intricate network of integrin signaling pathways, exhibiting both regulatory influences on other pathways and being subject to regulation itself. This phosphorylation event serves as a critical node in integrin-mediated signal transduction:

Crosstalk with Growth Factor Receptors:
Y773 phosphorylation creates docking sites for adaptor proteins that facilitate cross-communication between integrins and growth factor receptors. Research has demonstrated that ITGAV:ITGB3 binds to multiple growth factors including FGF1, FGF2, IGF1, IGF2, and NRG1, with Y773 phosphorylation being essential for proper signaling through these pathways . This phosphorylation enhances the formation of integrin-growth factor receptor complexes, leading to synergistic activation of downstream pathways including PI3K/Akt and MAPK cascades.

Regulation of Src Family Kinases (SFKs):
Y773 phosphorylation and SFK activity exhibit bidirectional regulation. While SFKs can phosphorylate ITGB3 at Y773, this phosphorylation in turn enhances SFK activation by displacing inhibitory interactions. This positive feedback loop amplifies integrin signaling during cell adhesion and migration events. Experimentally, SFK inhibitors can be used to assess the dependency of cellular processes on this feedback mechanism.

Connection to Cytoskeletal Dynamics:
Phosphorylation at Y773 influences the recruitment and activity of cytoskeletal regulators including talin, kindlin, filamin, and various GTPases (Rac1, RhoA, Cdc42). These interactions control focal adhesion turnover, stress fiber formation, and leading edge protrusion during migration. Live-cell imaging combined with phospho-specific antibodies reveals the spatial-temporal coordination between Y773 phosphorylation and cytoskeletal rearrangements.

Integration with Inflammatory Signaling:
Recent research has uncovered that ITGAV:ITGB3 binds to IL1B, with Y773 phosphorylation playing an essential role in IL1B signaling . This connection provides a molecular mechanism linking integrin activation to inflammatory responses, with potential implications for conditions such as atherosclerosis and tumor-associated inflammation.

How can phospho-ITGB3 (Y773) antibodies be used in cancer research and therapeutics development?

Phospho-ITGB3 (Y773) antibodies provide valuable tools for cancer research and therapeutic development, offering insights into tumor progression mechanisms and potential treatment targets. Cancer cells frequently exhibit dysregulated integrin signaling, with altered phosphorylation patterns contributing to enhanced migration, invasion, and metastasis.

Biomarker Development:
Immunohistochemical analysis using phospho-ITGB3 (Y773) antibodies in tumor samples can reveal activation states of integrin signaling pathways. Studies in breast carcinoma tissue have demonstrated successful detection of phosphorylated ITGB3 . Researchers can develop prognostic and predictive biomarker panels by quantifying Y773 phosphorylation levels in correlation with patient outcomes and treatment responses. Multi-parameter analysis combining Y773 phosphorylation with other signaling markers can stratify patients for targeted therapies.

Mechanisms of Treatment Resistance:
Enhanced ITGB3 Y773 phosphorylation has been implicated in resistance to various cancer therapies, including targeted agents and conventional chemotherapeutics. Integrins mediate cell adhesion-mediated drug resistance through activation of survival pathways. Researchers can use phospho-specific antibodies to monitor changes in Y773 phosphorylation during treatment and relapse, potentially identifying adaptive resistance mechanisms. Time-course experiments following drug treatment can reveal dynamic changes in phosphorylation status correlating with resistance development.

Therapeutic Target Validation:
The specific interaction between ITGAV:ITGB3 and growth factors like FGF1, FGF2, IGF1, and IGF2 depends on Y773 phosphorylation . This makes it a potential target for disrupting tumor growth and angiogenesis. High-throughput screening assays using phospho-ITGB3 (Y773) antibodies can identify compounds that modulate this phosphorylation event. Assessment of Y773 phosphorylation serves as a pharmacodynamic marker in preclinical models evaluating integrin-targeted therapeutics.

Methodological Approach:
For cancer research applications, combining phospho-ITGB3 (Y773) immunohistochemistry with multiplex immunofluorescence allows simultaneous visualization of phosphorylation status alongside markers of tumor progression (proliferation, invasion, angiogenesis). Tissue microarrays enable high-throughput analysis across large patient cohorts, while single-cell analysis techniques can reveal intratumoral heterogeneity in phosphorylation patterns.

What are the technical challenges in detecting transient phosphorylation events at ITGB3 Y773 and how can they be overcome?

Detecting transient phosphorylation events at ITGB3 Y773 presents several technical challenges due to the dynamic nature of integrin signaling. These challenges and their solutions include:

Challenge: Rapid Dephosphorylation During Sample Processing
Y773 phosphorylation can be rapidly lost due to phosphatase activity during cell lysis and sample preparation. To overcome this:

• Harvest samples directly into boiling SDS-PAGE sample buffer when possible

• Use comprehensive phosphatase inhibitor cocktails including sodium orthovanadate, sodium fluoride, β-glycerophosphate, and sodium pyrophosphate in all buffers

• Maintain samples at 4°C throughout processing and minimize handling time

• Consider crosslinking agents to preserve protein modifications prior to lysis for certain applications

Challenge: Low Abundance of Phosphorylated Forms
Even under stimulated conditions, only a fraction of total ITGB3 may be phosphorylated at Y773. To enhance detection:

• Implement phospho-enrichment strategies using titanium dioxide or immobilized metal affinity chromatography prior to analysis

• Use signal amplification methods such as tyramide signal amplification for immunohistochemistry

• Concentrate regions of interest through laser capture microdissection for focal adhesion-rich areas

• Consider proximity ligation assays to visualize specific interactions dependent on Y773 phosphorylation with enhanced sensitivity

Challenge: Temporal Dynamics of Phosphorylation
The timing of Y773 phosphorylation varies depending on stimuli and cell types, making it easy to miss peak phosphorylation. Solutions include:

• Conduct careful time-course experiments with narrow sampling intervals (e.g., 30 seconds, 1, 2, 5, 10, 30 minutes) following stimulation

• Implement live-cell imaging using genetically encoded biosensors that report on Y773 phosphorylation in real-time

• Use synchronization protocols to align cellular responses in population-based assays

• Consider microfluidic approaches for rapid stimulation and fixation with precise timing control

Challenge: Spatial Heterogeneity of Phosphorylation
Y773 phosphorylation often occurs in specific subcellular compartments like focal adhesions. To address this:

• Use high-resolution microscopy (confocal, TIRF, super-resolution) rather than whole-cell lysate approaches

• Implement subcellular fractionation to isolate focal adhesion-enriched fractions

• Consider single-cell analysis techniques to account for cell-to-cell variability

• Use computational image analysis for quantification of phosphorylation at specific subcellular locations

How do post-translational modifications beyond phosphorylation impact ITGB3 function and antibody detection?

Integrin beta-3 undergoes multiple post-translational modifications (PTMs) beyond phosphorylation that collectively regulate its function and can impact antibody detection. Understanding these modifications is crucial for accurate interpretation of phospho-ITGB3 (Y773) antibody results.

Glycosylation Effects:
ITGB3 contains multiple N-glycosylation sites that influence protein folding, heterodimer formation, and ligand binding. The calculated molecular weight of ITGB3 is approximately 87kDa, but the observed weight in Western blots is often around 110kDa due to extensive glycosylation . This discrepancy must be considered when interpreting band positions. Glycosylation can potentially mask epitopes, affecting antibody accessibility to the phospho-Y773 site. Researchers should consider deglycosylation treatments (PNGase F) in parallel samples to confirm antibody specificity when unexpected results occur.

Proteolytic Processing:
The ITGB3 ectodomain can undergo proteolytic cleavage by metalloproteases, generating fragments with altered mobility on SDS-PAGE. This processing can separate the phosphorylated cytoplasmic domain from the extracellular domain, complicating interpretation of Western blot results. When studying heavily proteolyzed samples (like wound fluid or inflammatory tissues), researchers should use protease inhibitors during sample preparation and consider using multiple antibodies targeting different ITGB3 domains for comprehensive analysis.

Ubiquitination and Sumoylation:
These modifications regulate ITGB3 turnover and trafficking. Ubiquitination can generate high-molecular-weight species that may be misinterpreted as non-specific bands in Western blots. Phosphorylation at Y773 has been shown to protect ITGB3 from ubiquitination in some contexts, creating an interdependent relationship between these modifications. When studying phosphorylation dynamics, parallel assessment of ubiquitination status provides valuable context for interpreting changes in phospho-Y773 signals.

Cross-regulation Between Modifications:
Phosphorylation of Y773 can influence other modifications on ITGB3, creating complex regulatory networks:

• Y773 phosphorylation alters the conformation of the cytoplasmic tail, exposing or concealing sites for other modifications

• Phosphorylation can recruit or repel enzymes that catalyze other modifications

• Competitive modification can occur when multiple PTMs target closely spaced residues

Methodological Approaches:
To comprehensively assess ITGB3 modifications and their interrelationships:

• Combine phospho-specific detection with other PTM-specific antibodies in multiplexed assays

• Implement mass spectrometry-based approaches to map the complete PTM landscape of ITGB3

• Use site-directed mutagenesis to create modification-specific mutants for functional studies

• Consider proximity labeling approaches to identify proteins that interact with ITGB3 in a modification-dependent manner

What are the common causes of inconsistent results with phospho-ITGB3 (Y773) antibodies and how can they be addressed?

Inconsistent results when working with phospho-ITGB3 (Y773) antibodies can arise from multiple sources. Understanding and systematically addressing these issues is essential for generating reliable data:

Variable Phosphorylation States:
The phosphorylation status of Y773 is highly dynamic and sensitive to numerous factors. To minimize variability:

• Standardize cell culture conditions rigorously (serum lots, passage number, confluence)

• Control precise timing between stimulation and harvesting (use timer and rapid processing)

• Include positive controls (e.g., cells treated with pervanadate to maximize phosphorylation)

• Implement synchronization protocols when appropriate to align cellular responses

Antibody Quality and Batch Variation:
Different production lots of the same antibody can show varying specificity and sensitivity. To mitigate:

• Validate each new antibody lot against previous lots using identical positive control samples

• Consider purchasing larger quantities of a single lot for long-term studies

• Maintain detailed records of antibody performance with specific lot numbers

• Store antibodies exactly as recommended (typically aliquoted at -20°C, avoid freeze-thaw cycles)

Sample Preparation Inconsistencies:
Variations in sample handling significantly impact phosphorylation detection. Standardize by:

• Using consistent lysis buffers with freshly added phosphatase inhibitors

• Maintaining strict temperature control throughout processing (always on ice)

• Standardizing protein quantification methods and loading equal amounts

• Processing all experimental samples simultaneously rather than in batches

Protocol Optimization Issues:
Suboptimal protocols can yield inconsistent results. Improve reliability by:

• Conducting careful titration experiments to determine optimal antibody concentration

• Optimizing blocking conditions (BSA is preferred over milk for phospho-epitopes)

• Extending wash steps to reduce background (4×10 minutes rather than short washes)

• Testing multiple antigen retrieval methods for IHC applications (citrate versus EDTA buffers)

Methodological Solutions:

• Implement a detailed standard operating procedure (SOP) for each application

• Use internal control samples across experiments for normalization

• Consider multiplexed detection methods that allow for simultaneous measurement of phosphorylated and total ITGB3

• Document all experimental conditions meticulously for troubleshooting

How can researchers validate the specificity of phospho-ITGB3 (Y773) antibody in their experimental systems?

Validating antibody specificity is crucial for generating reliable and reproducible data when working with phospho-ITGB3 (Y773) antibodies. A comprehensive validation strategy should include multiple approaches:

Genetic Validation:
The gold standard for specificity validation involves genetic manipulation of the target protein:

• Use ITGB3 knockout cell lines or tissues as negative controls - all specific signal should be absent

• Generate Y773F mutant (non-phosphorylatable) and Y773E mutant (phosphomimetic) for comparison

• Implement CRISPR/Cas9 genome editing to create endogenous Y773F mutations

• Use siRNA/shRNA knockdown of ITGB3 with rescue experiments (wild-type vs. Y773F) to confirm specificity

Biochemical Validation:
These approaches directly manipulate the phosphorylation status:

• Treat parallel samples with lambda phosphatase to remove all phosphorylation - phospho-specific signal should disappear

• Use kinase inhibitors known to regulate Y773 phosphorylation to demonstrate signal reduction

• Stimulate cells with activators known to enhance Y773 phosphorylation (Mn2+, growth factors, integrin ligands)

• Perform peptide competition assays using the immunizing phosphopeptide and non-phosphorylated counterpart

Analytical Validation:
These methods verify the identity of the detected proteins:

• Confirm the molecular weight matches the expected size for ITGB3 (approximately 87-110kDa)

• Perform immunoprecipitation with total ITGB3 antibody followed by Western blot with phospho-specific antibody and vice versa

• Use mass spectrometry to identify the immunoprecipitated protein and confirm phosphorylation status

• Compare results across multiple phospho-ITGB3 (Y773) antibodies from different vendors or clones

Context-Specific Validation:
Ensure the antibody works in your specific experimental context:

• Test antibody performance in all buffers and fixatives used in your protocols

• Validate across different sample types (cell lines, primary cells, tissue sections) relevant to your research

• Include biological controls where phosphorylation is known to be high or low

• For imaging applications, co-stain with markers of known subcellular structures (e.g., focal adhesions) to confirm expected localization pattern

Documentation and Reporting:
Thorough documentation of validation experiments is essential for rigor and reproducibility:

• Include validation data in supplementary materials of publications

• Report the specific catalog number, lot number, and dilution used

• Clearly describe all controls employed to verify specificity

• Consider submitting validation data to antibody validation repositories

What are the emerging roles of ITGB3 Y773 phosphorylation in pathological conditions beyond cancer?

While extensively studied in cancer, ITGB3 Y773 phosphorylation plays crucial roles in various other pathological conditions. Emerging research has illuminated its significance in several disease contexts:

Cardiovascular Disorders:
In thrombotic conditions, ITGB3 Y773 phosphorylation mediates platelet hyperactivation and excessive clot formation. Following integrin α-IIb/β-3 activation, Y773 phosphorylation enhances P-selectin (SELP) expression on activated platelets, reinforcing platelet aggregation . In atherosclerosis, endothelial dysfunction involves dysregulated integrin signaling, with aberrant Y773 phosphorylation contributing to inflammatory cell recruitment and plaque instability. Research using phospho-specific antibodies in atherosclerotic plaque samples has revealed spatial correlation between Y773 phosphorylation and regions of inflammatory activity.

Inflammatory and Autoimmune Diseases:
The discovery that ITGAV:ITGB3 binds to IL1B with Y773 phosphorylation essential for IL1B signaling has opened new avenues in inflammation research . Y773 phosphorylation functions as a molecular switch in immune cell trafficking across endothelial barriers. In models of rheumatoid arthritis, aberrant Y773 phosphorylation in synovial fibroblasts contributes to invasive behavior and cartilage destruction. Therapeutic strategies targeting this phosphorylation event show promise in preclinical models of inflammatory diseases.

Fibrotic Disorders:
Emerging evidence links ITGB3 Y773 phosphorylation to myofibroblast activation and excessive extracellular matrix production. In pulmonary fibrosis, TGF-β-induced Y773 phosphorylation mediates fibroblast-to-myofibroblast transition, with phospho-deficient Y773F mutants showing resistance to this process. Similar mechanisms operate in liver fibrosis, where hepatic stellate cell activation depends on proper integrin signaling through Y773 phosphorylation. Quantitative analysis of Y773 phosphorylation levels in fibrotic tissues correlates with disease severity and response to antifibrotic therapies.

Neurodegenerative Diseases:
In Alzheimer's disease, ITGB3 Y773 phosphorylation influences microglial responses to amyloid plaques. This phosphorylation event regulates microglial migration and phagocytic capacity, affecting plaque clearance efficiency. In cerebral ischemia models, endothelial ITGB3 Y773 phosphorylation modulates blood-brain barrier integrity, with heightened phosphorylation associated with increased permeability and edema formation. Pharmacological modulation of this phosphorylation event shows neuroprotective effects in preclinical stroke models.

How do advanced imaging techniques enhance our understanding of ITGB3 Y773 phosphorylation dynamics?

Advanced imaging techniques have revolutionized our ability to visualize and quantify ITGB3 Y773 phosphorylation with unprecedented spatiotemporal resolution. These methodologies offer unique insights into the dynamics and function of this critical signaling event:

Super-Resolution Microscopy:
Techniques such as STORM, PALM, and STED overcome the diffraction limit, allowing visualization of individual integrin clusters at nanometer resolution. These approaches reveal that Y773 phosphorylation occurs in distinct nano-domains within focal adhesions rather than uniformly across adhesion sites. By combining phospho-ITGB3 (Y773) antibody labeling with super-resolution imaging, researchers can map the precise spatial relationship between phosphorylated integrins and other adhesion complex components. Time-resolved super-resolution reveals the sequential recruitment of signaling molecules following Y773 phosphorylation with millisecond precision.

Live-Cell FRET-Based Biosensors:
Genetically encoded biosensors based on fluorescence resonance energy transfer (FRET) enable real-time visualization of Y773 phosphorylation in living cells. These biosensors typically contain the ITGB3 cytoplasmic domain flanked by fluorescent proteins that undergo FRET changes upon phosphorylation-induced conformational shifts. This approach reveals that Y773 phosphorylation occurs in rapid, localized pulses at the leading edge during cell migration, with distinct patterns in different microenvironments. Combined with optogenetic tools, these biosensors allow precise spatiotemporal control and monitoring of phosphorylation events.

Intravital Microscopy:
This technique enables imaging of ITGB3 Y773 phosphorylation in living organisms, providing physiologically relevant contexts. Using phospho-specific antibodies or FRET biosensors in transgenic animals, researchers can visualize Y773 phosphorylation during processes such as thrombosis, angiogenesis, or immune cell trafficking. These studies have revealed that Y773 phosphorylation dynamics differ significantly between in vitro and in vivo settings, with more complex regulation in tissue environments. Multiphoton intravital microscopy allows deeper tissue penetration for imaging phosphorylation events in intact organs.

Correlative Light and Electron Microscopy (CLEM):
This hybrid approach combines the specificity of fluorescence microscopy with the ultrastructural detail of electron microscopy. By immunolabeling phospho-ITGB3 (Y773) for fluorescence detection followed by electron microscopy of the same sample, researchers can correlate phosphorylation status with nanoscale architecture of adhesion structures. These studies reveal that Y773 phosphorylation correlates with specific ultrastructural conformations of integrin cytoplasmic domains and their associated cytoskeletal connections.

Analytical Considerations:
When implementing these advanced imaging approaches:

What computational approaches can integrate phospho-ITGB3 (Y773) data into systems-level understanding of integrin signaling?

Computational approaches have become essential for integrating phospho-specific data into a systems-level understanding of integrin signaling networks. These methodologies can transform discrete experimental observations about ITGB3 Y773 phosphorylation into comprehensive models with predictive power:

Network Analysis and Modeling:
Phosphorylation of ITGB3 at Y773 initiates complex signaling cascades involving multiple interacting proteins. Network analysis approaches can:

• Map the direct interactome of phosphorylated ITGB3 using phospho-specific pull-downs and mass spectrometry

• Generate dynamic models of information flow from Y773 phosphorylation to downstream effectors

• Identify network motifs (feedback loops, feed-forward circuits) that regulate Y773 phosphorylation

• Predict system-level responses to perturbations using ordinary differential equation-based models

The constructed networks reveal that Y773 phosphorylation serves as a critical node connecting adhesion signaling to growth factor, cytokine, and metabolic pathways .

Multi-omics Data Integration:
Comprehensive understanding requires integration of phospho-ITGB3 (Y773) data with other omics datasets:

• Correlate Y773 phosphorylation levels with transcriptomic changes to identify gene expression programs regulated by this modification

• Integrate phosphoproteomics data to position Y773 within the broader phosphorylation landscape during integrin activation

• Combine with interactomics data to identify protein complexes dependent on Y773 phosphorylation status

• Correlate with metabolomics data to understand how integrin signaling influences cellular metabolism

Multi-dimensional data visualization techniques (t-SNE, UMAP) can reveal patterns and relationships not apparent in single-omics analyses.

Machine Learning Applications:
Advanced computational methods can extract patterns and generate predictions:

• Develop classifiers to predict cellular phenotypes based on Y773 phosphorylation patterns in different contexts

• Use unsupervised learning to identify patient subgroups with distinct Y773 phosphorylation signatures

• Implement deep learning for image analysis to quantify subtle changes in phosphorylation patterns

• Employ reinforcement learning approaches to optimize experimental design for investigating Y773 phosphorylation

These approaches have successfully identified previously unrecognized relationships between ITGB3 phosphorylation patterns and disease outcomes.

Spatiotemporal Modeling:
The dynamics of Y773 phosphorylation vary across subcellular locations and over time:

• Develop agent-based models that simulate individual integrin molecules and their phosphorylation states

• Create reaction-diffusion models that account for spatial gradients in kinase and phosphatase activities

• Implement stochastic modeling approaches to capture the probabilistic nature of phosphorylation events

• Develop multiscale models linking molecular events to cellular behaviors and tissue-level phenomena

These models reveal emergent properties that arise from the collective behavior of many integrin molecules with varying phosphorylation states.